Trademark: CLONOSEQ 2034561
Word
CLONOSEQ
Device Descrption:
MAGNIFYING-GLASS IS LTR Q
ID
2034561
Trademark Type
Fancy, Figurative
Status
Registered: Registered/protected
Application Date
03 September 2019
Registration Date
03 September 2019
Renewal Date
03 September 2029
Owner(s)
Service
AJ Park
Goods and Services:
Class 1:
Genetic test kits for the detection and analysis of minimal residual disease in blood cancers for scientific purposes; genetic analysis test kits containing reagents for detecting, quantitating and characterizing immune cells in a biological sample for scientific research purposes; kits comprising primarily reagents, assays, enzymes and/or nucleotides for genetic research (other than for medical or veterinary use); chemical reagents for genetic research (other than for medical or veterinary use)
Genetic test kits for the detection and analysis of minimal residual disease in blood cancers for scientific purposes; genetic analysis test kits containing reagents for detecting, quantitating and characterizing immune cells in a biological sample for scientific research purposes; kits comprising primarily reagents, assays, enzymes and/or nucleotides for genetic research (other than for medical or veterinary use); chemical reagents for genetic research (other than for medical or veterinary use)
Class 42:
Providing scientific research services for medical purposes, namely, medical diagnostic assays and diagnostic and prognostic testing for residual disease, and the analysis, evaluation, and reporting of those test results to help healthcare professionals determine a patient's clinical diagnosis, the effectiveness of patient treatments, and to revise future treatments accordingly; scientific and medical research and development services; providing medical and scientific research information in the fields of pharmaceuticals and genetics; medical and scientific research in the field of cancer treatment and diagnosis
Providing scientific research services for medical purposes, namely, medical diagnostic assays and diagnostic and prognostic testing for residual disease, and the analysis, evaluation, and reporting of those test results to help healthcare professionals determine a patient's clinical diagnosis, the effectiveness of patient treatments, and to revise future treatments accordingly; scientific and medical research and development services; providing medical and scientific research information in the fields of pharmaceuticals and genetics; medical and scientific research in the field of cancer treatment and diagnosis